ArticleCureus2025
Awareness of Hepatitis B Among the General Population in Riyadh, Saudi Arabia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Patient awareness of viral hepatitis infection in Al-Madinah, Saudi Arabia: a cross-sectional study.Scientific reports · 2026Article
- Knowledge, Attitudes, and Preventive Practices Related to Hepatitis B Infection Among Adults in Saudi Arabia: A Nationwide Cross-Sectional Study.Healthcare (Basel, Switzerland) · 2026Article
- Hepatitis Management in Saudi Arabia: Trends, Prevention, and Key Interventions (2016-2025).Medicina (Kaunas, Lithuania) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatitis B, caused by the hepatitis B virus (HBV), remains a significant global public health challenge despite advances in vaccination and treatment. This study aims to evaluate the awareness, knowledge, and perceptions of hepatitis B among the general population in Riyadh, Saudi Arabia.
methodsA cross-sectional survey was conducted in Riyadh in 2024, involving 805 participants aged 18 years and above. Data were collected using a structured questionnaire that assessed demographic characteristics, general awareness, knowledge of transmission and prevention, testing history, and sources of information. Descriptive statistics and chi-squared tests were used for analysis.
resultsAmong the participants, 87% reported awareness of hepatitis B, though detailed knowledge about transmission and prevention revealed gaps. Awareness of blood transfusion as a transmission route was high (83.2%), while unprotected sex (49.3%) and mother-to-child transmission (43.2%) were less recognized. Vaccination was identified as a preventive measure by 83.5%, but misconceptions, such as the efficacy of hand washing (32%), were evident. Only 35.4% of participants had been tested for hepatitis B, highlighting low screening rates. Primary information sources included healthcare providers (57.1%) and the internet (57.5%), with social media cited by 41.5%. Gender, age, and educational background significantly influenced knowledge levels.
conclusionWhile general awareness of hepatitis B is high, critical gaps in detailed knowledge and testing behavior remain. Public health strategies should focus on correcting misconceptions, enhancing screening rates, and leveraging trusted information sources to improve the understanding and management of hepatitis B. This study provides valuable insights for policymakers aiming to bridge these knowledge gaps and enhance disease prevention efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.